RNA, U6 small nuclear 396, pseudogene (RNU6-396P)

RNA, U6 small nuclear 396, pseudogene (RNU6-396P) is a pseudogene derived from the U6 small nuclear RNA gene family[1][6]. U6 small nuclear RNA (snRNA) is an essential non-coding RNA component of the spliceosome, where it functions in the catalysis of intron removal from pre-messenger RNA during splicing[3][5]. However, the "-pseudogene" designation means RNU6-396P itself is a non-functional copy (it does not produce a functional U6 snRNA transcript or protein). Pseudogenes like RNU6-396P arise via genomic duplication or retrotransposition, and typically lack biological function; they do not participate directly in splicing[6]. There is no evidence that RNU6-396P has a disease-related role, serves as a therapeutic target, is biologically functional, or interacts with any drugs[1][6]. Special note: - RNU6-396P is not an active gene, protein, or receptor, and thus is not considered a therapeutic target or molecular entity of pharmacological interest. It is more accurately described as a genomic marker of past retrotransposition events[6]. - The entry is potentially misleading as a research or therapeutic "target" due to its pseudogene status and lack of biological or pharmacological relevance[1][6].

Other names

RNU6-396P